NEW YORK (GenomeWeb News) – Massachusetts General Hospital researchers have received a $5.4 million grant to use genome sequencing in studies aimed at discovering switches in Alzheimer's-linked genes and how these may be controlled by environmental factors.

The funding from the Cure Alzheimer's Fund (CAF) will support the second phase of the Alzheimer's Genome Project, which previously identified novel genes linked to Alzheimer's risk.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.